Literature DB >> 21677894

The Relationship between psychomotor vigilance performance and quality of life in obstructive sleep apnea.

In-Soo Lee1, Wayne Bardwell, Sonia Ancoli-Israel, Loki Natarajan, Jose S Loredo, Joel E Dimsdale.   

Abstract

OBJECTIVE: Patients with obstructive sleep apnea (OSA) commonly have cognitive complaints, particularly in attention, and report decreased quality of life. We examined how vigilance and sustained attention, as assessed by the Psychomotor Vigilance Task (PVT), were related to quality of life after controlling for apnea severity and depression in subjects with OSA. SUBJECTS AND METHODS: Fifty-seven patients with newly diagnosed and untreated OSA had their sleep monitored with polysomnography. Quality of life was assessed by the Short Form-36 health survey questionnaire (SF-36). Mood was assessed by the Center for Epidemiologic Studies-Depression (CES-D) Scale. After sleep monitoring and psychological assessments were performed, the 10-minute PVT was administered. The main outcome variables were PVT lapse count and average response time (RT). Simple correlations and multiple linear regression were used to examine the association between PVT performance and age, body mass index, sleep variables, apnea hypopnea index, oxygen desaturation index, and CES-D. RESULTS AND
CONCLUSION: Both the PVT lapse count and RT were significantly associated with the SF-36 physical component summary score (PCS). In multiple linear regression, PVT RT was an independent predictor of the SF-36 PCS (full model R(2) = 0.331, p = 0.003). PVT lapse was also an independent predictor of the SF-36 PCS (full model R(2) = 0.320, p = 0.004). However, neither PVT RT nor lapse was a significant independent predictor of the SF-36 mental component summary score (MCS). Only CES-D was an individual predictor of the SF-36 MCS (β = -0.676, p < 0.001). Impairments in sustained attention and vigilance may underlie the limitations in physical health-related quality of life reported by people with OSA, even after controlling for demographic variables, apnea severity, and depression.

Entities:  

Keywords:  Obstructive sleep apnea; SF-36; psychomotor vigilance task; quality of life

Mesh:

Year:  2011        PMID: 21677894      PMCID: PMC3113963          DOI: 10.5664/JCSM.1064

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  43 in total

1.  Adaptation of performance during a week of simulated night work.

Authors:  Nicole Lamond; Jill Dorrian; Heleh Burgess; Alex Holmes; Gregory Roach; Kirsty McCulloch; Adam Fletcher; Drew Dawson
Journal:  Ergonomics       Date:  2004-02-05       Impact factor: 2.778

Review 2.  Obstructive sleep apnoea syndrome: underestimated and undertreated.

Authors:  G J Gibson
Journal:  Br Med Bull       Date:  2005-03-29       Impact factor: 4.291

3.  Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night.

Authors:  D F Dinges; F Pack; K Williams; K A Gillen; J W Powell; G E Ott; C Aptowicz; A I Pack
Journal:  Sleep       Date:  1997-04       Impact factor: 5.849

4.  Racial differences in sleep-disordered breathing in African-Americans and Caucasians.

Authors:  S Redline; P V Tishler; M G Hans; T D Tosteson; K P Strohl; K Spry
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

5.  Relationship between obstructive sleep apnea severity and brain activation during a sustained attention task.

Authors:  Liat Ayalon; Sonia Ancoli-Israel; Allison A Aka; Benjamin S McKenna; Sean P A Drummond
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

Review 6.  Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review.

Authors:  Mark S Aloia; J Todd Arnedt; Jennifer D Davis; Raine L Riggs; Desiree Byrd
Journal:  J Int Neuropsychol Soc       Date:  2004-09       Impact factor: 2.892

7.  Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight?

Authors:  Asmus Vogel; Jette Stokholm; Anders Gade; Birgitte Bo Andersen; Anne-Mette Hejl; Gunhild Waldemar
Journal:  Dement Geriatr Cogn Disord       Date:  2004-01-20       Impact factor: 2.959

8.  Sleep-disordered breathing in community-dwelling elderly.

Authors:  S Ancoli-Israel; D F Kripke; M R Klauber; W J Mason; R Fell; O Kaplan
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea.

Authors:  Maree Barnes; R Douglas McEvoy; Siobhan Banks; Natalie Tarquinio; Christopher G Murray; Norman Vowles; Robert J Pierce
Journal:  Am J Respir Crit Care Med       Date:  2004-06-16       Impact factor: 21.405

Review 10.  Sleep deprivation and vigilant attention.

Authors:  Julian Lim; David F Dinges
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

View more
  13 in total

1.  Longer duration electroencephalogram arousals have a better relationship with impaired vigilance and health status in obstructive sleep apnoea.

Authors:  Brett Duce; Antti Kulkas; Juha Töyräs; Philip Terrill; Craig Hukins
Journal:  Sleep Breath       Date:  2020-05-30       Impact factor: 2.816

2.  Non-REM sleep-disordered breathing affects performance on the psychomotor vigilance task.

Authors:  Takuro Kitamura; Soichiro Miyazaki; Hiroshi Kadotani; Takashi Kanemura; Harun Bin Sulaiman; Shoko Takeuchi; Takahisa Tabata; Hideaki Suzuki
Journal:  Sleep Breath       Date:  2017-08-14       Impact factor: 2.816

3.  Depression, Obstructive Sleep Apnea and Psychosocial Health.

Authors:  Shazia Jehan; Evan Auguste; Seithikurippu R Pandi-Perumal; Jolaade Kalinowski; Alyson K Myers; Ferdinand Zizi; Madhu G Rajanna; Girardin Jean-Louis; Samy I McFarlane
Journal:  Sleep Med Disord       Date:  2017-10-27

4.  CPAP Adherence is Associated With Attentional Improvements in a Group of Primarily Male Patients With Moderate to Severe OSA.

Authors:  Sean Deering; Lin Liu; Tania Zamora; Joanne Hamilton; Carl Stepnowsky
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

5.  Impaired sustained attention and lapses are present in patients with mild obstructive sleep apnea.

Authors:  Gabriela Pontes Luz; Thais Moura Guimarães; Terri E Weaver; Luiz E Nery; Luciana Oliveira E Silva; Luciana Badke; Glaury Coelho; Aline Millani-Carneiro; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2015-11-12       Impact factor: 2.816

6.  Immediate effect of CPAP titration on perceived health related quality of life: a prospective observational study.

Authors:  Serena Iacono Isidoro; Adriana Salvaggio; Anna Lo Bue; Salvatore Romano; Oreste Marrone; Giuseppe Insalaco
Journal:  BMC Pulm Med       Date:  2016-12-01       Impact factor: 3.317

7.  Fatigue and sleepiness determine respiratory quality of life among veterans evaluated for sleep apnea.

Authors:  Denis Vinnikov; Paul D Blanc; Alaena Alilin; Moshe Zutler; Jon-Erik C Holty
Journal:  Health Qual Life Outcomes       Date:  2017-03-14       Impact factor: 3.186

8.  Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance.

Authors:  Matiram Pun; Sara E Hartmann; Michael Furian; Adrienna M Dyck; Lara Muralt; Mona Lichtblau; Patrick R Bader; Jean M Rawling; Silvia Ulrich; Konrad E Bloch; Marc J Poulin
Journal:  Front Physiol       Date:  2018-06-04       Impact factor: 4.566

9.  Upper Airway Resistance Syndrome Patients Have Worse Sleep Quality Compared to Mild Obstructive Sleep Apnea.

Authors:  Luciana Balester Mello de Godoy; Gabriela Pontes Luz; Luciana Oliveira Palombini; Luciana Oliveira E Silva; Wilson Hoshino; Thaís Moura Guimarães; Sergio Tufik; Lia Bittencourt; Sonia Maria Togeiro
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

10.  Analysis of Attention Subdomains in Obstructive Sleep Apnea Patients.

Authors:  Eunice N Simões; Catarina S Padilla; Marcio S Bezerra; Sergio L Schmidt
Journal:  Front Psychiatry       Date:  2018-10-04       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.